Skip to main content
. 2020 Dec 22;13(1):6. doi: 10.3390/pharmaceutics13010006

Scheme 1.

Scheme 1

Reagents and conditions: (a) 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), 1-hydroxybenzotriazole (HOBt), N-methylmorpholine (NMM), N,N-dimethylformamide (DMF), rt, 15 h.